Heqi Bu

558 total citations
18 papers, 453 citations indexed

About

Heqi Bu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Heqi Bu has authored 18 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Heqi Bu's work include Bioactive Natural Diterpenoids Research (8 papers), Cell death mechanisms and regulation (7 papers) and Autophagy in Disease and Therapy (5 papers). Heqi Bu is often cited by papers focused on Bioactive Natural Diterpenoids Research (8 papers), Cell death mechanisms and regulation (7 papers) and Autophagy in Disease and Therapy (5 papers). Heqi Bu collaborates with scholars based in China. Heqi Bu's co-authors include Junhui Cui, Zhaohong Wang, DIAN-LEI LIU, Luo Jiang, Sheng‐Zhang Lin, Hongfei Tong, Jianhong Zhang, Feng Shen, Hai Huang and Ye Li and has published in prestigious journals such as Phytomedicine, Evidence-based Complementary and Alternative Medicine and International Journal of Oncology.

In The Last Decade

Heqi Bu

18 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heqi Bu China 13 275 78 73 72 61 18 453
Srinivas Reddy Boreddy United States 7 353 1.3× 80 1.0× 27 0.4× 97 1.3× 51 0.8× 11 521
Jung-Chou Chen Taiwan 11 433 1.6× 53 0.7× 52 0.7× 107 1.5× 139 2.3× 11 616
Kanamata Reddy United States 15 470 1.7× 163 2.1× 38 0.5× 65 0.9× 80 1.3× 27 706
Alyssa Langfald United States 10 290 1.1× 102 1.3× 32 0.4× 69 1.0× 28 0.5× 18 488
Liping Xie China 13 399 1.5× 59 0.8× 29 0.4× 161 2.2× 43 0.7× 37 637
Xiao-Huang Xu Macao 10 346 1.3× 52 0.7× 68 0.9× 54 0.8× 75 1.2× 13 519
Takafumi Ando Japan 10 226 0.8× 65 0.8× 32 0.4× 101 1.4× 148 2.4× 14 492
Gabriela B. Iwanski United States 7 294 1.1× 86 1.1× 30 0.4× 41 0.6× 54 0.9× 8 612
Quangen Gao China 14 403 1.5× 102 1.3× 82 1.1× 118 1.6× 41 0.7× 17 624
Young‐Rak Cho South Korea 14 272 1.0× 50 0.6× 20 0.3× 79 1.1× 72 1.2× 35 512

Countries citing papers authored by Heqi Bu

Since Specialization
Citations

This map shows the geographic impact of Heqi Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heqi Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heqi Bu more than expected).

Fields of papers citing papers by Heqi Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heqi Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heqi Bu. The network helps show where Heqi Bu may publish in the future.

Co-authorship network of co-authors of Heqi Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Heqi Bu. A scholar is included among the top collaborators of Heqi Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heqi Bu. Heqi Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Zhaohong, et al.. (2025). Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1α/LARS1/mTOR axis. Phytomedicine. 139. 156437–156437. 2 indexed citations
2.
3.
4.
Bu, Heqi, et al.. (2020). <p>AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells</p>. OncoTargets and Therapy. Volume 13. 8533–8545. 32 indexed citations
5.
LIU, DIAN-LEI, et al.. (2020). Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis. Translational Cancer Research. 9(7). 4148–4161. 6 indexed citations
6.
Bu, Heqi, et al.. (2019). Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells. Translational Cancer Research. 8(5). 1782–1794. 2 indexed citations
7.
Bu, Heqi, et al.. (2019). Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells. Translational Cancer Research. 8(5). 1782–1794. 16 indexed citations
8.
Bu, Heqi, Feng Shen, & Junhui Cui. (2019). <p>The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo</p>. OncoTargets and Therapy. Volume 12. 7467–7476. 24 indexed citations
9.
Shen, Feng, et al.. (2018). Prognostic accuracy of different lymph node staging systems in rectal adenocarcinoma with or without preoperative radiation therapy. Japanese Journal of Clinical Oncology. 48(7). 625–632. 13 indexed citations
10.
Bu, Heqi, Kai Chen, Hao Zhang, et al.. (2016). Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK. Oncology Reports. 35(4). 1941–1949. 43 indexed citations
11.
Zhang, Hao, et al.. (2015). Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells. Oncology Reports. 33(6). 3015–3023. 18 indexed citations
12.
LIU, DIAN-LEI, et al.. (2014). Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway. Molecular Medicine Reports. 10(6). 3027–3034. 23 indexed citations
13.
Chen, Hui, Jianhong Zhang, Luo Jiang, et al.. (2013). Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Oncology Reports. 30(2). 589–595. 56 indexed citations
14.
Bu, Heqi, DIAN-LEI LIU, Weitian Wei, et al.. (2013). Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Oncology Reports. 31(2). 975–982. 54 indexed citations
15.
Lin, Shengzhang, Jianhong Zhang, Hui Chen, et al.. (2013). Involvement of Endoplasmic Reticulum Stress in Capsaicin-Induced Apoptosis of Human Pancreatic Cancer Cells. Evidence-based Complementary and Alternative Medicine. 2013. 1–12. 30 indexed citations
16.
17.
Bu, Heqi, Luo Jiang, Hui Chen, et al.. (2012). Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. International Journal of Oncology. 41(3). 949–958. 34 indexed citations
18.
LIU, DIAN-LEI, Heqi Bu, Hui Chen, et al.. (2011). Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. International Journal of Oncology. 40(4). 1049–1057. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Srinivas Reddy Boreddy Breakdown of academic impact, for papers by Jung-Chou Chen Breakdown of academic impact, for papers by Kanamata Reddy Breakdown of academic impact, for papers by Alyssa Langfald Breakdown of academic impact, for papers by Liping Xie Breakdown of academic impact, for papers by Xiao-Huang Xu Breakdown of academic impact, for papers by Takafumi Ando Breakdown of academic impact, for papers by Gabriela B. Iwanski Breakdown of academic impact, for papers by Quangen Gao Breakdown of academic impact, for papers by Young‐Rak Cho
Rankless by CCL
2026